Vaccines to Prevent Pneumococcal Community-Acquired Pneumonia - 02/11/18
, Susanne M. Huijts, MD, PhD bRésumé |
Streptococcus pneumoniae is the most frequent pathogen in community-acquired pneumonia and also causes invasive diseases like bacteremia and meningitis. Young children and elderly are especially at risk for pneumococcal diseases and are, therefore, eligible for pneumococcal vaccination in most countries. This reviews provides an overview of the current epidemiology of pneumococcal infections, history and evidence of available pneumococcal polysaccharide and conjugate vaccines, and current recommendations.
Le texte complet de cet article est disponible en PDF.Keywords : Streptococcus pneumoniae, Community-acquired pneumonia, Invasive pneumococcal disease, Pneumococcal vaccines, Pneumococcal conjugate vaccine, Pneumococcal polysaccharide vaccine
Plan
| Disclosure Statement: C.H. van Werkhoven reports speaker fees and financial support for thesis printing from Pfizer, and speaker fees from Merck/MSD. S.M. Huijts reports financial support from Pfizer for thesis printing. Both authors were involved in research funded by Pfizer through their institution. |
Vol 39 - N° 4
P. 733-752 - décembre 2018 Retour au numéro
Article précédent
- Guidelines to Manage Community-Acquired Pneumonia
- Richard G. Wunderink
- Adjunctive Therapies for Community-Acquired Pneumonia
- Adrian Ceccato, Miquel Ferrer, Enric Barbeta, Antoni Torres
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?